Stabilization of enteric coated dosage form
    1.
    发明授权
    Stabilization of enteric coated dosage form 失效
    肠溶包衣剂形式的稳定化

    公开(公告)号:US5068110A

    公开(公告)日:1991-11-26

    申请号:US379727

    申请日:1989-07-14

    IPC分类号: A61K9/48

    CPC分类号: A61K9/4891

    摘要: The present invention is a stabilized enteric-coated pharmaceutical dosage form and processes for the preparation thereof. Dissolution stability after storage of the dosage form under high stress conditions is improved by an enteric-coated dosage form having an enteric coating wherein the coating is of the acrylic resin kind of from 14 mg/cm.sup.2 to 24 mg/cm.sup.2 or an enteric coating wherein the coating is of the acetate kind of from 14 mg/cm.sup.2 to 24 mg/cm.sup.2 and having a second coating of hydrophilic coating for example, hydroxypropyl cellulose, hydroxymethyl cellulose or hydroxypropylmethyl cellulose.

    摘要翻译: 本发明是一种稳定的肠溶包衣药物剂型及其制备方法。 通过具有肠溶衣的肠溶衣剂形式,其中所述涂层为14mg / cm 2至24mg / cm 2的丙烯酸树脂类型或肠溶衣,其中在高应激条件下储存剂型之后的溶解稳定性得到改善,其中 该涂层的醋酸盐类型为14mg / cm 2至24mg / cm 2,并且具有亲水涂层的第二涂层,例如羟丙基纤维素,羟甲基纤维素或羟丙基甲基纤维素。

    Rapamycin 29-enols
    8.
    发明授权
    Rapamycin 29-enols 失效
    雷帕霉素29-烯醇

    公开(公告)号:US06677357B2

    公开(公告)日:2004-01-13

    申请号:US10224971

    申请日:2002-08-22

    IPC分类号: A61K31445

    CPC分类号: C07D405/06 C07D493/08

    摘要: This invention provides non-immunosuppressive rapamycin 29-enols, which are useful as neurotrophic agents, in the treatment of solid tumors, and vascular disease.

    摘要翻译: 本发明提供了用于治疗实体瘤和血管疾病的非免疫抑制雷帕霉素29-烯醇,其可用作神经营养剂。